TYRA-430
TYR430-101
Phase 1 small_molecule active
Quick answer
TYRA-430 for Metastatic Hepatocellular Carcinoma is a Phase 1 program (small_molecule) at Tyra Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tyra Biosciences
- Indication
- Metastatic Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active